Tests of prolactin secretion in diagnosis of prolactinomas

scientific article published on June 2, 1979

Tests of prolactin secretion in diagnosis of prolactinomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(79)91841-5
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0140673679918415?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0140673679918415?httpAccept=text/xml
P698PubMed publication ID86882

P2093author name stringD. Doyle
J. A. Thomson
J. G. Ratcliffe
P. Macpherson
E. A. Cowden
G. M. Teasdale
P2860cites workTransient Bitemporal Hemianopsia During Pregnancy After Treatment of Galactorrhea-Amenorrhea Syndrome with BromocriptineQ28330320
Functional evaluation of prolactin secretion: a guide to therapyQ34494876
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasmaQ36719102
Serum Prolactin Response to Thyrotropin-Releasing Hormone and Metoclopramide in Patients with Prolactin-Secreting Tumors before and after Transsphenoidal SurgeryQ39724975
Clinical neuroendocrinologyQ40098176
Transsphenoidal microsurgery for pituitary tumors associated with hyperprolactinemiaQ40153114
Nomifensine: Diagnostic Test in Hyperprolactinemic States*Q40468038
Pituitary Autonomy in Hyperprolactinemic Secondary Amenorrhea: Results of Hypothalamic-Pituitary TestingQ41250550
Clinical and endocrine features of hyperprolactinaemic amenorrhoeaQ42443937
Basal and TRH-stimulated prolactin in patients with pituitary tumoursQ42443987
Borderline variants of the normal pituitary fossaQ45022148
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumoursQ48196801
Galactorrhea: a study of 235 cases, including 48 with pituitary tumorsQ48306540
Long-term Treatment of Galactorrhoea and Hypogonadism with BromocriptineQ48555334
Neuroendocrine Dysfunction in Galactorrhea-Amenorrhea After Oral Contraceptive UseQ66961276
Prolactin secretion in sixty-five patients with galactorrheaQ67268702
Hyperprolactinaemia in renal diseaseQ67403297
Treatment of patients with prolactinomasQ67459568
Prolactin-secreting pituitary microadenomas: roentgenologic diagnosisQ69818026
P433issue8127
P407language of work or nameEnglishQ1860
P304page(s)1155-1158
P577publication date1979-06-01
1979-06-02
P1433published inThe LancetQ939416
P1476titleTests of prolactin secretion in diagnosis of prolactinomas
P478volume1

Reverse relations

cites work (P2860)
Q36716713A practical approach to the investigation of the hyperprolactinaemic patient
Q69846459Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease
Q41600845Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function
Q42861742Assessment of pituitary function.
Q72477356Autonomous prolactin secretion in schizophrenic male on long-term neuroleptic therapy
Q42745258Computed tomographic abnormalities of the pituitary in hyperprolactinaemic women.
Q54099399Cushing's disease with hyperprolactinaemia treated by transsphenoidal hypophysectomy
Q33614609Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
Q42436308Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia
Q47824731Fansidar resistant falciparum malaria in Indonesia
Q36717238Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy
Q42446070Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas
Q69510562High-resolution computed tomography in pituitary microadenoma: is seeing believing?
Q50124492Hyperflexion cervical cord injury in a children's car seat
Q81060204Hyperprolactinemia
Q38724656Hyperprolactinemia: neuroendocrine and diagnostic aspects
Q40140971Investigation of hypothalamic-pituitary disease
Q42459987Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests
Q34490393Management of selected patients with hyperprolactinaemia by partial hypophysectomy
Q34256619Management of the Hirsute Woman
Q48555216Multiple intracranial metastases from a prolactin secreting pituitary tumour
Q66705091Nomifensine test for investigation of hyperprolactinaemia
Q70463287Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas
Q42491895Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
Q58553376Pharmacokinetics and Pharmacodynamics of Ropinirole in Patients with Prolactinomas
Q72405495Pituitary tumors
Q69936731Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease
Q40090274Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic Applications
Q42359810Prolactinoma: a question of rational treatment
Q52096963Psychiatric and social aspects of premenstrual complaint.
Q42464882Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia
Q40211156Surgical management of pituitary adenoma.
Q42477898TRH raises cytosolic Ca2+ in human adenomatous lactotrophs
Q66704102TRH test for prolactinoma
Q70681763Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone
Q39467835The circadian rhythms of thyrotrophin and prolactin secretion
Q42527843The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia
Q43954553The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
Q42456573The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour
Q69057400The natural history of untreated microprolactinomas
Q47210992The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery
Q40283167The use of bromocriptine in obstetrics and gynecology.
Q42463352The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
Q34490406Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.
Q71353674Trends in the management of prolactinomas
Q41573466Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms

Search more.